Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD
Demonstrating the "clinical meaningfulness" of slowing early cognitive decline in clinically normal (CN) older adults with elevated amyloid b (Ab+ is critical for Alzheimer's disease secondary prevention trials and for understanding early cognitive progression.
Alzheimer's Dementia